EUVIMEDEUVIMED entdecken
Crossref

Quantification of circulating clonal plasma cells by multiparametric flow cytometry as a prognostic marker in patients with newly diagnosed multiple myeloma

Pandurangan Sathya, Smita Kayal, B H Srinivas, Abdoul Hamide, Rakhee Kar iD

International Journal of Laboratory Hematology · 2023

DOI: 10.1111/ijlh.14156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2023. Verfasst von Pandurangan Sathya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Jawaharlal Institute of Post-Graduate Medical Education and Research, Pondicherry, India. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: JIPMER Intramural Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies have shown that the quantification of circulating clonal plasma cells (cCPCs) in peripheral blood using flow cytometry could be used as a prognostic predictor of poor outcome in multiple myeloma (MM).

Methods

In 66 newly diagnosed MM, cCPCs were quantified (cCPC%) and analysed for association with outcome and survival. Single‐tube combined surface (CD45/CD19/CD138/CD38/CD56/CD27/CD81 as per availability) and cytoplasmic (kappa/lambda) staining was done using pre‐titrated volumes of antibodies. In 26 patients, repeat cCPC% was assessed post‐induction therapy. For association studies, treatment response has been taken as good (VGPR and above) and poor (PR and below). All statistical analyses were performed with SPSS software version 16.0.

Results

There was no significant association between cCPC% at baseline with staging ( p = 0.43), β 2 ‐microglobulin ( p = 0.27) and albumin ( p = 0.08). There was a significant difference between the pre‐induction and post‐induction cCPC% ( p = 0.0001). The patients were segregated using a cut‐off of ≥0.197 and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHumansPlasma CellsPrognosisFlow CytometryAntigens, CD19

Stichwörter der Autor:innen

circulating clonal plasma cellsflow cytometrymultiple myelomaresponse assessmentsurvival

Substanzen

Antigens, CD19

Autor:innen und Institutionen

  • Department of Pathology, Jawaharlal Institute of Post-Graduate Medical Education and Research, Pondicherry, India.
  • Department of Medical Oncology, Jawaharlal Institute of Post-Graduate Medical Education and Research, Pondicherry, India.
  • Department of Medicine, Jawaharlal Institute of Post-Graduate Medical Education and Research, Pondicherry, India.

ORCID-Profile: Rakhee Kar

Förderung

  • JIPMER Intramural Fund

Zitieren

APA

Sathya, P., Kayal, S., Srinivas, B. H., Hamide, A., & Kar, R. (2023). Quantification of circulating clonal plasma cells by multiparametric flow cytometry as a prognostic marker in patients with newly diagnosed multiple myeloma. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14156

Vancouver

Sathya P, Kayal S, Srinivas BH, Hamide A, Kar R. Quantification of circulating clonal plasma cells by multiparametric flow cytometry as a prognostic marker in patients with newly diagnosed multiple myeloma. International Journal of Laboratory Hematology. 2023. doi:10.1111/ijlh.14156

BibTeX
@article{Sathya2023,
  author = {Sathya, Pandurangan and Kayal, Smita and Srinivas, B H and Hamide, Abdoul and Kar, Rakhee},
  title = {Quantification of circulating clonal plasma cells by multiparametric flow cytometry as a prognostic marker in patients with newly diagnosed multiple myeloma},
  journal = {International Journal of Laboratory Hematology},
  year = {2023},
  doi = {10.1111/ijlh.14156}
}
Kostenlos starten →